Cash Flow from Operating Activities: A company's cash flows from operations.
Alamar Biosciences, Inc. (ALMR) had Cash Flow from Operating Activities of $-46.40M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$33.55M |
|
$-13.34M |
|
$12.90M |
|
$20.64M |
|
$48.68M |
|
$-15.14M |
|
$1.89M |
|
$-13.25M |
|
$-13.25M |
|
$-13.34M |
|
$-13.34M |
|
$-13.34M |
|
$-13.34M |
|
$-15.14M |
|
$-14.07M |
|
69.11M |
|
69.11M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$317.69M |
|
$15.24M |
|
$60.34M |
|
$378.03M |
|
$33.48M |
|
-- |
|
$40.84M |
|
$74.32M |
|
$303.70M |
|
$302.26M |
|
$303.70M |
|
69.47M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-46.40M |
$-109.83M |
|
$247.75M |
|
$34.91M |
|
$126.44M |
|
$91.53M |
|
$8.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
61.54% |
|
-45.13% |
|
-45.13% |
|
-- |
|
-39.49% |
|
-39.77% |
|
$-51.11M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.24 |
|
1.55 |
|
57.98 |
|
-4.39% |
|
-4.41% |
|
-3.53% |
|
-4.39% |
|
$4.37 |
|
$-0.74 |
|
$-0.67 |
|